These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29115569)

  • 1. Glioma stem cells and their non-stem differentiated glioma cells exhibit differences in mitochondrial structure and function.
    Kim EJ; Jin X; Kim OR; Ham SW; Park SH; Kim H
    Oncol Rep; 2018 Jan; 39(1):411-416. PubMed ID: 29115569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
    Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
    Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
    Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
    Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid binding protein 7 as a marker of glioma stem cells.
    Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
    Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
    Lin Y; Sun H; Dang Y; Li Z
    Oncol Rep; 2018 Feb; 39(2):687-694. PubMed ID: 29251326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.
    Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y
    Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines.
    Santoni G; Nabissi M; Amantini C; Santoni M; Ricci-Vitiani L; Pallini R; Maggi F; Morelli MB
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
    Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
    Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
    Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target.
    Chen S; Zhao H; Deng J; Liao P; Xu Z; Cheng Y
    J Cell Biochem; 2013 Dec; 114(12):2795-808. PubMed ID: 23836528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From single-cell to spatial transcriptomics: decoding the glioma stem cell niche and its clinical implications.
    Cao L; Lu X; Wang X; Wu H; Miao X
    Front Immunol; 2024; 15():1475235. PubMed ID: 39355251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
    Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
    Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic state of glioma stem cells and nontumorigenic cells.
    Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
    Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
    Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.